PPARG and metabolic dysfunction-associated steatohepatitis: However, further investigations are required to elucidate the mechanisms regulated by hepatocyte-specific PPARγ and if they play a role in the interplay between hepatocytes and nonparenchymal cells, that may offset the therapeutic effects of whole-body PPARγ activation in patients with NASH.